RANDAL SCOTT plan to sell securities of BridgeBio Pharma, Inc. under Form 144

RANDAL SCOTT filed Form 144 to notify SEC of plan to sell 2196 units of BridgeBio Pharma, Inc. securities around 2026-06-24, with aggregate market value of $150,711.48. The total outstanding units is 195861242.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 05/15/2026, sold 10000 units for $671456.00;